• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质瘤的治疗:印度视角

Therapy for glioma: Indian perspective.

作者信息

Munshi A, Jalali R

机构信息

Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India.

出版信息

Indian J Cancer. 2009 Apr-Jun;46(2):127-31. doi: 10.4103/0019-509x.49150.

DOI:10.4103/0019-509x.49150
PMID:19346646
Abstract

Central nervous system (CNS) are rare neoplasms with considerable heterogeneity and variation. The most common primary lesions of CNS are gliomas. A majority of the data about the demography and management of gliomas has emerged from the west. However, there may be considerable variation in the presentation, behavior, and response to treatment between patients in the western world and the Asian population. This article discusses gliomas with special reference to data from oncology centers in India.

摘要

中枢神经系统(CNS)肿瘤较为罕见,具有相当大的异质性和变异性。中枢神经系统最常见的原发性病变是胶质瘤。关于胶质瘤的人口统计学和治疗的数据大多来自西方。然而,西方世界的患者与亚洲人群在临床表现、行为和对治疗的反应方面可能存在相当大的差异。本文特别参考印度肿瘤中心的数据讨论胶质瘤。

相似文献

1
Therapy for glioma: Indian perspective.胶质瘤的治疗:印度视角
Indian J Cancer. 2009 Apr-Jun;46(2):127-31. doi: 10.4103/0019-509x.49150.
2
Diagnostic and prognostic molecular markers in common adult gliomas.常见成人脑胶质瘤的诊断和预后分子标志物。
Expert Rev Mol Diagn. 2010 Jul;10(5):637-49. doi: 10.1586/erm.10.44.
3
Low-grade gliomas.低级别胶质瘤
Handb Clin Neurol. 2012;105:437-50. doi: 10.1016/B978-0-444-53502-3.00001-X.
4
Management of diffusely infiltrating glioma in the elderly.老年弥漫性浸润性胶质瘤的管理
Curr Opin Oncol. 2015 Nov;27(6):502-9. doi: 10.1097/CCO.0000000000000236.
5
Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.《神经肿瘤学杂志》:2021年世界卫生组织中枢神经系统肿瘤分类后IDH突变在胶质瘤中的诊断和治疗意义
J Neurooncol. 2023 May;162(3):457-459. doi: 10.1007/s11060-023-04317-3. Epub 2023 May 22.
6
Evidence-based adjuvant therapy for gliomas: current concepts and newer developments.基于证据的神经胶质瘤辅助治疗:当前概念与新进展
Indian J Cancer. 2009 Apr-Jun;46(2):96-107. doi: 10.4103/0019-509x.49147.
7
[A practical guide for the management of gliomas].[胶质瘤管理实用指南]
Bull Cancer. 2007 Sep;94(9):817-22.
8
Advances in the molecular genetics of gliomas - implications for classification and therapy.胶质母细胞瘤的分子遗传学进展——对分类和治疗的影响。
Nat Rev Clin Oncol. 2017 Jul;14(7):434-452. doi: 10.1038/nrclinonc.2016.204. Epub 2016 Dec 29.
9
A retrospective survey of patients with malignant gliomas treated in the neuro-oncological care system under the Universal National Health Insurance program in Taiwan.台湾全民健康保险制度下神经肿瘤照护体系中恶性神经胶质瘤患者的回顾性调查。
J Clin Neurosci. 2011 Jun;18(6):784-8. doi: 10.1016/j.jocn.2010.10.016. Epub 2011 Apr 19.
10
Primary dissemination of high-grade gliomas in children: experiences from four studies of the Pediatric Oncology and Hematology Society of the German Language Group (GPOH).儿童高级别胶质瘤的原发性播散:来自德语区儿科肿瘤与血液学会(GPOH)四项研究的经验
J Neurooncol. 2005 Apr;72(2):179-83. doi: 10.1007/s11060-004-3546-5.

引用本文的文献

1
DDX3X dynamics, glioblastoma's genetic landscape, therapeutic advances, and autophagic interplay.DDX3X 动力学、胶质母细胞瘤的遗传全景、治疗进展和自噬相互作用。
Med Oncol. 2024 Oct 5;41(11):258. doi: 10.1007/s12032-024-02525-z.
2
Survival and quality of life analysis in glioblastoma multiforme with adjuvant chemoradiotherapy: a retrospective study.多形性胶质母细胞瘤辅助放化疗的生存及生活质量分析:一项回顾性研究
Rep Pract Oncol Radiother. 2022 Dec 29;27(6):1026-1036. doi: 10.5603/RPOR.a2022.0113. eCollection 2022.
3
Immunohistochemical expression of glial fibrillary acidic protein and CAM5.2 in glial tumors and their role in differentiating glial tumors from metastatic tumors of central nervous system.
胶质纤维酸性蛋白和CAM5.2在胶质肿瘤中的免疫组化表达及其在鉴别胶质肿瘤与中枢神经系统转移瘤中的作用。
J Neurosci Rural Pract. 2015 Oct-Dec;6(4):499-503. doi: 10.4103/0976-3147.168426.